Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Application
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWRifabutin-d7 is intended for use as an internal standard for the quantification of rifabutin (Item No. 16468) by GC- or LC-MS. Rifabutin is a rifamycin antibiotic.1,2 It is active against a variety of Gram-positive and Gram-negative bacteria, including 81 clinical isolates of H. pylori (MIC50 = 0.25 µg/ml), as well as S. aureus, S. pyogenes, and C. trachomatis (MICs = 0.004, 0.005, and ~0.008 µg/ml, respectively). Rifabutin (0.5 µg/ml) is also active against 302 strains of M. tuberculosis.2 It inhibits protein synthesis via inhibition of DNA-dependent RNA polymerase (RNAP) activity.2 Rifabutin (10, 20, or 40 mg/kg) reduces the number of spleen, lung, and liver colony forming units (CFUs) in mouse models of disseminated Mycobacterium avium complex (MAC) infection.3 Formulations containing rifabutin have been used in the treatment of H. pylori infection.
WARNING This product is not for human or veterinary use.
1. Rifampin and rifabutin resistance mechanism in Helicobacter pylori. Antimicrob. Agents Chemother. 43(6), 1497-1499 (1999).
2. Antimicrobial activity of rifabutin. Clin. Infect. Dis. 22(Supp. 1), S3-S14 (1996).
3. Comparative in vivo activities of rifabutin and rifapentine against Mycobacterium avium complex. Antimicrob. Agents Chemother. 38(2), (1994).